Dow Jones received a payment from EQS/DGAP to publish this press release.
EQS-News / 26/02/2018 / 18:22 UTC+8
?*For Immediate Release*?
????????????
*China Shineway Pharmaceutical Group Limited *(*Stock Code: 2877*)
*Shineway worked overtime throughout the Chinese New Year holiday
to produce anti-flu medications*
(Hong Kong, 26 February 2018) ---- The largest Chinese medicine injections,
soft capsules and granules manufacturer in the PRC, *China Shineway
Pharmaceutical Group Limited* ("Shineway") (HKEx stock code: 2877) today
told investors in a monthly newsflash the following:
1. To meet the strong demand for anti-flu medications, our production
workshops did not take time off, but worked overtime throughout the Chinese
New Year long holiday to make Qingkailing Injection, Qingkailing Soft
Capsule, Paediatric Qingfei Huatan Granule, TCM Formula Granules etc., in an
effort to safeguard the public's health.
2. Huamoyan Granule, Dan Deng Tong Nao Capsule, and Qingkailing Soft Capsule
are Shineway's exclusive oral products included in the National Drug
Reimbursement List. Shineway will place a heavy focus to nurture each of
these high growth potential products for three years to reach multi-hundred
million in sales. Huamoyan Granule is the only synovitis focused innovative
prescription drugs for osteoarthritis treatment in the country, and can
effectively resolve anti-inflammatory pain, repair damaged synovium, and
delay degeneration of cartilage. Dan Deng Tong Nao Capsule is our exclusive
medicine originated from the Yi tribe for treating stroke caused by blood
stasis. Its curative effect in the treatment of stroke is highly notable,
and effectively improve patients' daily living activities during recovery
period and facilitate restoration of brain functions. Qingkailing Soft
Capsule is used for nasal congestion, nasal discharge, sore throat, fever
and other upper respiratory tract symptoms caused by viruses and bacteria.
It is an effective remedy in curing respiratory tract infections acquired in
the community. These three exclusive oral products are set to serve as one
of the catalysts for sales growth.
End
*About China Shineway Pharmaceutical Group Limited (Stock Code: 2877)*
China Shineway Pharmaceutical Group Limited is one of the largest modern
Chinese medicines manufacturers in the PRC. The Group is listed on the Main
Board of Hong Kong Stock Exchange and is also a Hang Seng Composite Index
constituent.
Media Contact:
China Shineway Pharmaceutical Group Limited
Mr. Randy Hung ¦ Tel: (852) 3521-0816 ¦ randyhung@shineway.com.hk
Document: http://n.eqs.com/c/fncls.ssp?u=RARCIYRPTD [1]
Document title: Shineway worked overtime throughout the Chinese New Year
holiday to produce anti-flu medications
26/02/2018 Dissemination of a Marketing Press Release, transmitted by EQS
Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=5853e8561cd982d88bde9940117118e1&application_id=657635&site_id=vwd&application_name=news
(END) Dow Jones Newswires
February 26, 2018 05:22 ET (10:22 GMT)
© 2018 Dow Jones News
